https://www.selleckchem.com/products/abt-199.html
And the pharmacokinetic properties of AHSYB in rats with acute blood stasis and the differences between normal and acute blood stasis syndrome rats were also investigated. The results showed that the compound was poorly absorbed (∼0.3%) and the AUC0-t, AUC0-∞ and F were all significantly lower (P less then 0.05) in acute blood stasis syndrome rats, suggesting that disease condition may alter the body metabolism by enhancing metabolite enzyme activity.Rapid, sensitive, selective and accurate LC/MS/MS method was developed for quantitative
Mi piace
Commento
Condividi
